Gilead raises sales outlook to include COVID-19 treatment remdesivir – Reuters India

Gilead raises sales outlook to include COVID-19 treatment remdesivir – Reuters India

Gilead Sciences Inc on Thursday posted worse-than-expected quarterly results, but raised its 2020 sales forecast to include revenue from its antiviral drug remdesivir, one of the only treatments shown to help COVID-19 patients.

Read More…

You May Also Like